- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05380167
Efficacy Long-term Dietary Nitrate Consumption to Plasma Nitrite Conversion
May 18, 2022 updated by: Gary Miller, Wake Forest University
Efficacy and Variability in Plasma Nitrite Levels During Long-term Supplementation With Nitrate Containing Beetroot Juice
The objective of this study was to determine the chronic effects of beetroot juice supplementation on the acute (90-minute post nitrate consumption) efficacy of converting dietary nitrate to plasma nitrate and plasma nitrite in healthy middle-to-older aged adults.
the investigators were also interested in determining the effect of this intervention on fasting levels of plasma nitrate and nitrite over time.
Furthermore, the number of participants classified as "non-responders" was determined based on increases in plasma nitrite achieved using tolerable volumes of beetroot juice by other studies.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27109
- Wake Forest University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Middle and Older (40-80 year-old) men and women
- Body mass index between 18.5 - 30.0 kg/m2
- Able to provide own transportation to study testing visits
- Able to consume study beverages
- Able to speak and read English
Exclusion Criteria:
- Tobacco user (smoke or chew), including e-cigarettes
- Known conditions of: diabetes mellitus (type 1 or 2), atrophic gastritis, hypo- or hyperthyroidism, gout, history of kidney stones, history of hypotension, cardiovascular disease, chronic obstructive pulmonary disease, inflammatory bowel diseases, impaired liver or kidney function
- Current or recent (last 3 months) treatment for cancer
- Current use of the following medications: Phosphodiesterase type 5 inhibitors, nitroglycerin or nitrate preparations, proton pump inhibitors, medication for hypothyroidism, antacid and heartburn medications
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: BRJ Nitrate
This arm consumed daily for 12 weeks a 70 mL bottle of beetroot juice containing 380 mg of nitrate.
|
Participants in this group drank daily for 12 weeks a 70 mL bottle of Beet It Sport drink with nitrate.
|
Placebo Comparator: BRJ Placebo
This arm consumed daily for 12 weeks a 70 mL bottle of beetroot juice containing 0 mg of nitrate.
|
Participants in this group drank daily for 12 weeks a 70 mL bottle of Beet It Sport drink without nitrate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fasting Plasma Nitrate
Time Frame: Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
|
Concentration of nitrate in the plasma obtained at the start of each testing visit
|
Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
|
Fasting Plasma Nitrite
Time Frame: Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
|
Concentration of nitrite in the plasma obtained at the start of each testing visit
|
Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
|
90 minute plasma Nitrate
Time Frame: Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
|
Concentration of nitrate in the plasma obtained 90 minutes following the consumption of the intervention arm's assigned beverage
|
Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
|
90 minute plasma Nitrite
Time Frame: Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
|
Concentration of nitrite in the plasma obtained 90 minutes following the consumption of the intervention arm's assigned beverage
|
Collected at baseline (week 0), end of week 1, week 2, week 3, week 4, week 8, and week 12
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2017
Primary Completion (Actual)
May 1, 2019
Study Completion (Actual)
May 1, 2019
Study Registration Dates
First Submitted
May 12, 2022
First Submitted That Met QC Criteria
May 12, 2022
First Posted (Actual)
May 18, 2022
Study Record Updates
Last Update Posted (Actual)
May 25, 2022
Last Update Submitted That Met QC Criteria
May 18, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB000022922
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases in Old Age
-
Geunyeong ChaRecruiting
-
University of ZagrebHealth Centre Zagreb - Centre (Dom zdravlja Zagreb - Centar)CompletedCardiovascular Diseases in Old AgeCroatia
-
Michigan State UniversityUniversity of MichiganCompletedCardiovascular Diseases in Old Age
-
Georgia Southern UniversityAuburn UniversityCompletedCardiovascular Diseases | Sleep | Aging | Cardiovascular Diseases in Old AgeUnited States
-
University of WashingtonNational Institute of Nursing Research (NINR)CompletedFalls (Accidents) in Old AgeUnited States
-
Joel BelminUnknownFalls (Accidents) in Old AgeFrance
-
Samsung Medical CenterCompletedGait Disorders in Old AgeKorea, Republic of
-
Yun-Hee KimSamsung ElectronicsCompletedGait Disorders in Old AgeKorea, Republic of
-
Nova Scotia Health AuthorityNot yet recruitingFrailty | Cardiovascular Diseases in Old Age | TAVI
-
Edinburgh Biosciences LtdOnorach ClinicalRecruitingCataract in Old AgeLithuania, Latvia, Romania
Clinical Trials on BRJ Nitrate
-
Wake Forest UniversityCompletedSarcopenia | Old Age; Atrophy
-
Washington University School of MedicineThe Foundation for Barnes-Jewish HospitalActive, not recruiting
-
Wuerzburg University HospitalRecruiting
-
Gladwin, Mark, MDNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Failure | Preserved Ejection Fraction | Pulmonary; HypertensionUnited States
-
Karolinska InstitutetKarolinska University HospitalCompletedHypertension | Cardiovascular DiseaseSweden
-
Heinrich-Heine University, DuesseldorfCompleted
-
University of VirginiaCompletedArterial Stiffness | Vascular DilationUnited States
-
Queen's UniversityCompletedHeart Failure, Systolic
-
Edith Cowan UniversityFlinders University; The University of Western AustraliaCompleted
-
University of Colorado, BoulderRecruitingChronic Kidney DiseaseUnited States